Tailored to specific drug property and different needs associated with various development stages, SinoT will provide conventional, fit-for-purpose and enabling formulation development solutions and data packages, with the aims to help clients to speed up and shorten development cycle, save API consumption in early stages, and thus enable their products to reach market early and cost-effectively, bringing more benefits to patients.
SinoT has successfully manufactured hundreds of batches of clinical samples/products for over 90+ clients. Those samples have been used for clinical trials (CT) across the globe, including China, the United States, Europe, Australia, Canada and Janpan.
Based on the established advanced formulation R&D platforms, and leveraging on its competences in drug product development and manufacture, SinoT provides the CRO/CDMO services for new drug candidates.